American Portfolios Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
American Portfolios Advisors's GILD Position: Q3 2022 in Review
American Portfolios Advisors increased its Gilead Sciences (GILD) stake by 206% in Q3 2022, buying an estimated $955K and bringing the position to 22,488 shares worth $1.39M. The position accounts for 0.06% of the portfolio, ranked #328.
American Portfolios Advisors first reported a position in GILD in Q4 2017 and has held it in 20 quarters since. The position peaked at $2.14M in Q1 2020. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.
- American Portfolios Advisors held 22,488 shares of Gilead Sciences worth $1.39M as of Q3 2022.
- American Portfolios Advisors bought 15,148 Gilead Sciences shares in Q3 2022, an estimated $955K.
- Gilead Sciences made up 0.06% of American Portfolios Advisors's portfolio in Q3 2022, its #328 holding.
- American Portfolios Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's Gilead Sciences position peaked at $2.14M in Q1 2020.
- 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.